Document is current
Any future updates will be listed below
-
Authors
Esplin, Edward D. https://orcid.org/0000-0001-9205-3756
Hanson, Casey https://orcid.org/0000-0001-7818-6552
Wu, Si
Horning, Aaron M. https://orcid.org/0000-0003-3247-0798
Barapour, Nasim
Nevins, Stephanie A.
Jiang, Lihua
Contrepois, Kévin
Lee, Hayan https://orcid.org/0000-0003-0571-3192
Guha, Tuhin K.
Hu, Zheng
Laquindanum, Rozelle
Mills, Meredith A.
Chaib, Hassan
Chiu, Roxanne
Jian, Ruiqi
Chan, Joanne
Ellenberger, Mathew
Becker, Winston R.
Bahmani, Bahareh
Khan, Aziz https://orcid.org/0000-0002-6459-6224
Michael, Basil
Weimer, Annika K. https://orcid.org/0000-0001-9944-8769
Esplin, D. Glen
Shen, Jeanne https://orcid.org/0000-0002-1519-0308
Lancaster, Samuel
Monte, Emma
Karathanos, Thomas V. https://orcid.org/0000-0003-1754-3872
Ladabaum, Uri
Longacre, Teri A.
Kundaje, Anshul https://orcid.org/0000-0003-3084-2287
Curtis, Christina
Greenleaf, William J. https://orcid.org/0000-0003-1409-3095
Ford, James M. https://orcid.org/0000-0002-2513-7025
Snyder, Michael P. https://orcid.org/0000-0003-0784-7987
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U2CCA233311)
U.S. Department of Health & Human Services | National Institutes of Health (S10OD025212)
- License Information
-
More Information
Article History
Received: 20 October 2023
Accepted: 29 August 2024
First Online: 30 October 2024
Competing interests
: M.P.S. is a cofounder and scientific advisor of Personalis, SensOmics, Qbio, January AI, Fodsel, Filtricine, v Protos, RTHM, Iollo, Marble Therapeutics, Crosshair Therapeutics, NextThought and Mirvie. He is a scientific advisor of Jupiter, Neuvivo, Swaza, Mitrix, Yuvan, TranscribeGlass and Applied Cognition. A. Kundaje has affiliations with Biogen (consultant), SerImmune (scientific advisory board (SAB)), RavelBio (scientific cofounder and SAB) and PatchBio (SAB). K.C. is currently an AstraZeneca employee. W.J.G. has affiliations with Guardant Health (consultant and SAB), Protillion Biosciences (scientific cofounder) and 10x and has licenced patents associated with ATAC-seq. E.D.E. is an employee and stockholder of Labcorp, and advisor and stockholder of Taproot Health, Exir Bio and ROMTech. The other authors declare no competing interests.
